Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.05. | Inari Medical, Inc.: Inari Medical Announces the Release of 2022 Ethos and Sustainability Report | - | GlobeNewswire (USA) | ||
INARI MEDICAL Aktie jetzt für 0€ handeln | |||||
22.05. | Inari Medical, Inc.: Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients | 1 | GlobeNewswire (USA) | ||
22.05. | Here's Why You Should Retain Inari Medical (NARI) Stock Now | 1 | Zacks | ||
19.05. | Inari Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
09.05. | Looking Into Inari Medical's Return On Invested Capital | 1 | Benzinga.com | ||
04.05. | Inari Medical (NARI) Q1 Earnings Top, Revenues Rise Y/Y | - | Zacks | ||
03.05. | Inari Medical beats Q1 top and bottom line estimates; raises FY23 outlook | 1 | Seeking Alpha | ||
03.05. | Inari Medical, Inc.: Inari Medical Reports First Quarter 2023 Financial Results | 273 | GlobeNewswire (Europe) | IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous... ► Artikel lesen | |
02.05. | Inari Medical, Inc.: Inari Medical to Present at the Bank of America 2023 Healthcare Conference | - | GlobeNewswire (USA) | ||
13.04. | Inari Medical, Inc.: Inari Medical to Announce First Quarter 2023 Financial Results | 2 | GlobeNewswire (USA) | ||
05.04. | Here's Why You Should Retain Inari Medical (NARI) Stock Now | 2 | Zacks | ||
16.03. | Why Shares of Inari Medical Rose This Week | 2 | The Motley Fool | ||
06.03. | Inari Medical, Inc.: FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System | 3 | GlobeNewswire (USA) | ||
01.03. | Inari Medical (NARI) Q4 Earnings Beat, Revenues Rise Y/Y | 2 | Zacks | ||
28.02. | Analysts are bullish on Inari Medical following Q4 results | 2 | MassDevice | ||
27.02. | Inari Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
27.02. | Inari Medical GAAP EPS of -$0.11 beats by $0.06, revenue of $107.8M beats by $2.95M, guidance reaffirmed | 1 | Seeking Alpha | ||
27.02. | Inari Medical, Inc.: Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results | 448 | GlobeNewswire (Europe) | IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous... ► Artikel lesen | |
24.02. | Inari Medical Earnings Preview | 1 | Benzinga.com | ||
17.02. | Here's Why You Should Retain Inari Medical (NARI) Stock Now | 4 | Zacks |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 110,35 | -1,12 % | Carl Zeiss Meditec-Aktie mit leichten Kursgewinnen (107,80 €) | Im Plus liegt derzeit die Aktie von Carl Zeiss Meditec . Der jüngste Kurs betrug 107,80 Euro. Ein Preisanstieg von 2,81 Prozent steht gegenwärtig für die Carl Zeiss Meditec-Aktie zu Buche. Das Wertpapier... ► Artikel lesen | |
ECKERT & ZIEGLER | 40,160 | -0,99 % | EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG: Eckert & Ziegler veranstaltet erstes Radionuklid-Theranostik-Forum in Boston, MA | EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG
/ Schlagwort(e): Konferenz/Sonstiges
Eckert & Ziegler veranstaltet erstes Radionuklid-Theranostik-Forum in Boston, MA
30.05.2023... ► Artikel lesen | |
MEDTRONIC | 77,98 | -0,26 % | Titan Medical Inc (2): Titan Medical licenses IP to Medtronic for $8M (U.S.) | ||
INTUITIVE SURGICAL | 296,70 | +0,08 % | Intuitive Surgical Unusual Options Activity | ||
TELADOC HEALTH | 23,210 | +0,30 % | Teladoc - Nicht jede gute Idee verdient sofort Geld | Die Geschäftsidee von Teladoc ist sowohl beeindruckend als auch vielversprechend. Das Unternehmen wurde im Jahr 2002 gegründet und ist seit 2015 an der NYSE gelistet. Es hat ein Netzwerk von über 55.000... ► Artikel lesen | |
THERMO FISHER | 484,40 | +0,08 % | RECIPHARM AB: Statement from Arranta Bio on settlement of Thermo Fisher litigation | ||
BECTON DICKINSON | 237,00 | -0,21 % | BD continues to expand in Ireland | ||
DEXCOM | 116,36 | -0,02 % | Where DexCom Stands With Analysts | ||
BOSTON SCIENTIFIC | 48,300 | +0,65 % | Six Boston Scientific Benefits That Support Employee Mental Health | NORTHAMPTON, MA / ACCESSWIRE / May 30, 2023 / Boston ScientificOne in five American adults has a diagnosable mental health condition. Yet all too often, our friends, co-workers, neighbors and family... ► Artikel lesen | |
BAXTER | 38,600 | -0,77 % | Dividendenbekanntmachungen (01.06.2023) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,195 USD 0,1824 EUR ALLIANCE TRUST PLC GB00B11V7W98 0,0618 GBP 0,0719 EUR ALLSTATE CORPORATION US0200021014 0... ► Artikel lesen | |
RESMED | 206,40 | -0,48 % | RESMED INC: Statement of CDIs on issue - RMD | ||
ZIMMER BIOMET | 121,10 | +2,54 % | What 16 Analyst Ratings Have To Say About Zimmer Biomet Holdings | ||
TANDEM DIABETES | 22,720 | +0,35 % | The Latest Analyst Ratings for Tandem Diabetes Care | ||
INSULET | 268,00 | +1,06 % | Minimales Kursplus bei der Insulet-Aktie (254,7209 €) | Im US-amerikanischen Wertpapierhandel ist die Insulet-Aktie gegenwärtig unauffällig. Zuletzt zahlten Investoren für das Papier 273,02 US-Dollar. Einen geringen Wertanstieg von 0,14 Prozent zeigt die... ► Artikel lesen | |
STAAR SURGICAL | 54,46 | +3,34 % | STAAR Surgical Company Bottom Line Retreats In Q1, but beats estimates | WASHINGTON (dpa-AFX) - STAAR Surgical Company (STAA) revealed earnings for first quarter that decreased from the same period last year but beat the Street estimates.The company's earnings came... ► Artikel lesen |